Virtual Reality for Palliative Care

Phase-Based Progress Estimates
Mayo Clinic Florida, Jacksonville, FL
Palliative Care
Virtual Reality - Behavioral
All Sexes
What conditions do you have?

Study Summary

The purpose of this study is to assess whether virtual reality technology can reduce anxiety, depression, and emotional distress screening scores in palliative care patients.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Palliative Care

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: Baseline, post-intervention approximately 30 minutes

Baseline, post-intervention approximately 30 minutes
Change in anxiety
Change in emotional distress

Trial Safety

Safety Progress

1 of 3

Other trials for Palliative Care

Trial Design

1 Treatment Group

Virtual reality intervention in palliative care patients
1 of 1
Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Virtual Reality · No Placebo Group · N/A

Virtual reality intervention in palliative care patients
Experimental Group · 1 Intervention: Virtual Reality · Intervention Types: Behavioral
First Studied
Drug Approval Stage
How many patients have taken this drug
Virtual Reality
Completed Phase 3

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, post-intervention approximately 30 minutes
Closest Location: Mayo Clinic Florida · Jacksonville, FL
Photo of Jacksonville 1Photo of Jacksonville 2Photo of Jacksonville 3
2007First Recorded Clinical Trial
1 TrialsResearching Palliative Care
87 CompletedClinical Trials

Who is running the clinical trial?

Mayo ClinicLead Sponsor
2,860 Previous Clinical Trials
3,686,141 Total Patients Enrolled
5 Trials studying Palliative Care
130,271 Patients Enrolled for Palliative Care
Chimere Bruning, PA-CPrincipal InvestigatorMayo Clinic

Eligibility Criteria

Age 18+ · All Participants · 5 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have a terminal or end-stage condition with an expected prognosis of a year or less.
You are an established palliative care patient.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.